Connection

Rebecca Bechhold to Prognosis

Back to Details
This is a "connection" page, showing publications Rebecca Bechhold has written about Prognosis.
Rebecca Bechhold
Connection Strength
0.022
Prognosis
  1. EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast Cancer. J Clin Oncol. 2015 May 10; 33(14):1609-19.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.